Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Current Leases: 2019-2025

Historic Current Leases for Northwest Biotherapeutics (NWBO) over the last 7 years, with Sep 2025 value amounting to $399,000.

  • Northwest Biotherapeutics' Current Leases rose 55.86% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $399,000, marking a year-over-year increase of 55.86%. This contributed to the annual value of $326,000 for FY2024, which is 3.82% up from last year.
  • Northwest Biotherapeutics' Current Leases amounted to $399,000 in Q3 2025, which was down 10.94% from $448,000 recorded in Q2 2025.
  • In the past 5 years, Northwest Biotherapeutics' Current Leases ranged from a high of $448,000 in Q2 2025 and a low of $170,000 during Q1 2021.
  • For the 3-year period, Northwest Biotherapeutics' Current Leases averaged around $334,182, with its median value being $369,000 (2023).
  • Per our database at Business Quant, Northwest Biotherapeutics' Current Leases plummeted by 55.73% in 2021 and then soared by 156.00% in 2025.
  • Northwest Biotherapeutics' Current Leases (Quarterly) stood at $317,000 in 2021, then increased by 11.67% to $354,000 in 2022, then fell by 11.30% to $314,000 in 2023, then rose by 3.82% to $326,000 in 2024, then surged by 55.86% to $399,000 in 2025.
  • Its Current Leases was $399,000 in Q3 2025, compared to $448,000 in Q2 2025 and $390,000 in Q1 2025.